Organizations Filed Purposes:
CHAI'S MISSION IS TO SAVE LIVES AND REDUCE THE BURDEN OF DISEASE IN LOW-AND MIDDLE-INCOME COUNTRIES AROUND THE WORLD. WE AIM TO STRENGTHEN THE GOVERNMENT AND INDIGENEOUS PRIVATE HEALTH SYSTEMS TO CREATE AND SUSTAIN HIGH-QUALITY HEALTH SYSTEMS IN THE COUNTRIES WHERE WE WORK.
THE CLINTON HEALTH ACCESS INITIATIVE, INC. (CHAI) IS A GLOBAL HEALTH ORGANIZATION COMMITTED TO SAVING LIVES AND REDUCING THE BURDEN OF DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES.
OUR PROGRAMS AIM TO SAVE LIVES AND REDUCE DISEASE, WHILE HELPING GOVERNMENTS CREATE SUSTAINABLE HEALTH SYSTEMS. WE OPERATE 11 PROGRAMS ACROSS FOUR HEALTH AREAS, WITH A GLOBAL TEAM OF SCIENCE, BUSINESS, AND TECHNICAL EXPERTS SUPPORTING THE ENTIRE ORGANIZATION.INFECTIOUS DISEASES: FOUR INFECTIOUS DISEASES: HIV & AIDS, MALARIA, TUBERCULOSIS AND HEPATITIS CAUSE THE MAJORITY OF DEATHS IN THE LOW- AND- MIDDLE INCOME COUNTRIES AROUND THE WORLD. CHAI HAS BUILT ON THE EXPERTISE OF STAFF, AND EXPERIENCE DEVELOPED WITH OUR HIV WORK, TO ADDRESS EACH OF THESE DISEASES IN PARTNERSHIP WITH GOVERNMENTS, DONORS, AND OTHER KEY STAKEHOLDERS. THIS WORK HAS HELPED SAVE THE LIVES OF OVER 11 MILLION PEOPLE WHO OTHERWISE WOULD HAVE DIED FROM HIV/AIDS. TODAY OVER 19 MILLION PEOPLE LIVING WITH THE DISEASE ARE RECEIVING TREATMENT, AN INCREASE OF OVER 150 PERCENT OVER THE PAST DECADE. OVER 900,000 CHILDREN ARE RECEVING TREATMENT, FROM LESS THAN 100,000 WHEN CHAI'S WORK BEGAN, AND THE COST OF MEDICATIONS HAS FALLEN SIGNIFCANTLY. CHAI'S EFFORTS TO TRACK AND TREAT MALARIA CASES, WITH THE GOAL OF ELMINATION, HAS HELPED LEAD TO SIGNIFICANT DECLINES IN MALARIA PREVALENCE. OVER THE LAST FIVE YEARS (SINCE CHAI BEGAN OPERATIONS IN THE REGIONS), MALARIA HAS BEEN REDUCED BY 67 PERCENT IN THE GREATER MEKONG AND 50 PERCENT IN OUR FOCUS COUNTRIES IN CENTRAL AMERICA. CHAI HAS HELPED TO SIGNIFICANTLY REDUCE THE COSTS OF LIFESAVING TREATMENTS FOR TUBERCULOSIS AND HEPATITIS, INCLUDING A 97 PERCENT REDUCTION IN COST-PER-PATIENT TREATED FOR HEPATITIS C. OVER 100,000 PATIENTS HAVE BEEN TREATED FOR HEPATITIS C WITH CHAI SUPPORT.
WOMEN & CHILDREN'S HEALTH: WOMEN AND CHILDREN SUFFER THE GREATEST BURDEN FROM DISEASE GLOBALLY. CHAI HAS SIGNIFICANTLY INCREASED ACCESS TO RECOMMENDED TREATMENTS FOR DIARRHEA AND PNEUMONIA, THE LARGEST KILLERS OF CHILDREN UNDER FIVE; MADE CRITICAL VACCINES THAT PROTECT AGAINST CHILDHOOD ILLNESSES MORE AFFORDABLE; IS COMBATTING CHRONIC MALNUTRITION; AND IS DRAMATIALLY AND SUSTAINABLY REDUCING MATERNAL AND NEWBORN DEATHS AND ENSURING WOMEN HAVE ACCESS TO THE TOOLS THEY NEED TO SAFELY PLAN THER FAMILIES TO IMPROVE HEALTH OUTCOMES AND ECONOMIC WELL-BEING. THROUGH THIS WORK, CHAI HAS SIGNIFICANTLY INCREASED ACCESS TO LIFESAVING TREATMENTS FOR DIARRHEA (ZINC AND ORAL REHYDRATION SALTS) AND PNEUMONIA, INCLUDING OPTIMAL MEDICATIONS AND OXYGEN THERAPY, AS WELL AS TOOLS FOR DIAGNOSIS. CHAI'S WORK TO SAVE THE LIVES OF WOMEN AND NEWBORNS THROUGH INTEGRATING HEALTH SYSTEMS AND INCREASING ACCESS TO LIFESAVING CARE HAS CONTRIBUTED TO SUSTAINED AND SIGNFICANT REDUCTIONS IN DEATH IN COUNTRIES WHERE WE WORK, INCLUDING A NEARLY 40 PERCENT REDUCTION IN MATERNAL MORTALITY AND A 43 PERCENT REDUCTION IN NEWBORN DEATHS IN A 12- MONTH PERIOD IN TARGET STATES OF NORTHERN NIGERIA. CHAI HAS ALSO HELPED TO SIGNIFICANTLY LOWER THE COST OF LIFESAVING MEDICAL EQUIPMENT AND FAMILY PLANNING TO SAVE THE LIVES OF WOMEN AND IS HELPING GOVERMENTS DECREASE CHRONIC MALNUTRITION THROUGH DEVELOPMENT OF LOCALLY-BASED, FORTIFIED FOODS, IMPROVING NUTRITION PROGRAMS AND REDUCING ANEMIA. THIS WORK HAS REACHED NEARLY 3 MILLION WOMEN AND CHILDREN IN INDIA AND OVER 100,000 IN RWANDA. CHAI HAS ALSO SIGNIFICANTLY DECREASED THE COSTS OF LIFESAVING CHILDHOOD VACCINATIONS INCLUDING THE ROTAVIRUS VACCINE (67 PERCENT COST REDUCITION, PENTAVALENT VACCINE (45 PERCENT COST REDUCTION), AND THE INACTIVATED POLIO VACCINE (57 PERCENT COST REDUCTION). AN ESIMATED 157,000 DEATHS PER YEAR HAVE BEEN AVERTED THROUGH THE ROLLLOUT OF ROTAVIRUS AND PENTAVALENT VACCINES.
NON-COMMUNICABLE DISEASES: EACH YEAR, 15 MILLION PEOPLE DIE FROM NON-COMMUNICABLE DISEASES BETWEEN THE AGES OF 30 AND 69. OVER 85 PERCENT OF THESE DEATHS OCCUR IN LOW-AND MIDDLE-INCOME COUNTRIES. CARDIOVASCULAR DISEASES ACCOUNT FOR THE MOST DEATHS, FOLLOWED BY CANCERS, RESPIRATORY DISEASES, AND DIABETES. CHAI BEGAN WORK IN THIS AREA WITH THE LAUNCH OF OUR CANCER PROGRAM IN 2015. CANCER IS A GROWING ISSUE IN SUB-SAHARHAN AFRICA, WHERE INCIDENCE IS PROJECTED TO INCREASE BY 85 PERCENT IN THE NEXT 15 YEARS. CHAI IS WORKING WITH THE AMERICAN CANCER SOCIETY TO LOWER THE COST OF LIFESAVING CHEMOTHERAPIES, INCREASE ACCESS TO DIAGNOSIS AND TREATMENT, AND HELP GOVERNMENTS DEVELOP PLANS TO COMPREHENSIVELY MANAGE THE DISEASE. CHAI'S WORK HAS HELPED TO LOWER THE COSTS OF 20 ESSENTIAL CANCER TREATMENTS BY 59 PERCENT. IN ETHOPIA, TREATMENT RATES FOR CANCER PATIENTS HAS MORE THAN DOUBLED. CHAI ALSO LAUNCHED A PROGRAM TO REDUCE DEATHS FROM CERVICAL CANCER IN 2019. WITHIN SIX MONTHS OF LAUNCHING THE PROGRAM, CHAI NEGOTIATED A PRICE REDUCTION FOR TWO LIFESAVING TOOLS: HPV TEST KIDS FOR SCREENING AND PORTABLE THERMAL ABLATION DEVICES FOR TREATMENT. THE AGREEMENTS ENABLED POINT-OF-CARE TREATMENT AT LESS THAN US$0.50 PER WOMAN TREATED, ASSUMING A DEVICE CAN BE USED AT LEAST 2,000 TIMES.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Ira Magaziner | CHIEF EXECUTIVE OFFICER | 40 | $379,389 |
Kelly Mccrystal | CHIEF STRATEGY OFF./EVP/INTERIM CFO | 40 | $283,990 |
David Ripin | EVP, INFECTIOUS DISEASES/CHIEF SCIENCE OFFICER | 40 | $283,799 |
Alice Kang'Ethe | CHIEF OPERATING OFFICER | 40 | $266,733 |
Yigeremu Abebe Asemerie | VP, COUNTRY DIRECTOR, ETHIOPIA | 40 | $259,486 |
Linda Denicola | CHIEF FINANCIAL OFFICER (UNTIL 9/19) | 40 | $259,180 |
Young Joshua Chu | EVP, GLOBAL VACCINCES & CANCER | 40 | $224,000 |
Owens Wiwa | EVP, GLOBAL RESOURCES | 40 | $219,414 |
Gerald Macharia | VP, EAST AND SOUTHERN AFRICA/COUNTRY DIRECTOR | 40 | $192,260 |
Alan Staple | VP, GLOBAL MARKETS | 40 | $182,569 |
Joseph Harwell | CLINICAL SENIOR DIRECTOR | 40 | $178,946 |
Justin Cohen | DIRECTOR, GLOBAL MALARIA | 40 | $174,194 |
Paul Domanico | SENIOR DIRECTOR, GLOBAL HEALTH SCIENCES | 40 | $169,007 |
Mphu Ramatlapeng | EVP, IMPLEMENTATION | 40 | $160,000 |
Palesa Mohasoa | FMR INTERIM CFO/CRNT INTL CONTROLLER | 40 | $143,031 |
Tachi Yamada | CHAIR OF THE BOARD | 1 | $0 |
Ann Veneman | BOARD MEMBER | 1 | $0 |
Alan Schwartz | BOARD MEMBER | 1 | $0 |
Robert W Selander | BOARD MEMBER | 1 | $0 |
Bruce Lindsey | BOARD MEMBER | 5 | $0 |
Mala Gaonkar | BOARD MEMBER | 1 | $0 |
Paul Farmer | BOARD MEMBER | 1 | $0 |
Mark Dybul | BOARD MEMBER | 1 | $0 |
Dame Sally Davies | BOARD MEMBER | 1 | $0 |
Aliko Dangote | BOARD MEMBER | 1 | $0 |
Awa Marie Coll-Seck | BOARD MEMBER (UNTIL 6/19) | 1 | $0 |
William J Clinton | BOARD MEMBER | 5 | $0 |
Chelsea Clinton | BOARD MEMBER | 10 | $0 |
Raymond Chambers | BOARD MEMBER | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202013219349304446_public.xml